Published in JAMA on September 16, 1992
The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res (1995) 1.45
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol (2009) 0.97
Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest (1995) 0.92
A review of the first year of Medicare coverage of erythropoietin. Health Care Financ Rev (1994) 0.89
When should we delay highly active antiretroviral therapy? J Gen Intern Med (1999) 0.89
Trends in use, cost, and outcomes of human recombinant erythropoietin, 1989-98. Health Care Financ Rev (1999) 0.85
Patients, populations and policy: patient outcomes in chronic kidney disease. Trans Am Clin Climatol Assoc (2001) 0.78
Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med (1996) 9.46
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med (1999) 7.68
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology (2001) 5.54
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09
Mesoscale iron enrichment experiments 1993-2005: synthesis and future directions. Science (2007) 4.92
Pre-enrollment reimbursement patterns of Medicare beneficiaries enrolled in "at-risk" HMOs. Health Care Financ Rev (1982) 4.81
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med (2001) 4.81
Risk-adjusted Medicare capitation rates using ambulatory and inpatient diagnoses. Health Care Financ Rev (1996) 4.71
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med (1994) 4.64
Small-bowel changes in dermatitis herpetiformis. Lancet (1966) 4.49
A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization. Nature (2000) 4.36
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA (1999) 3.85
Twenty years of Medicare and Medicaid: covered populations, use of benefits, and program expenditures. Health Care Financ Rev (1985) 3.78
Hospital readmissions in the Medicare population. N Engl J Med (1984) 3.68
Costs and charges associated with three alternative techniques of hysterectomy. N Engl J Med (1996) 3.35
The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA (1991) 3.29
Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1992) 3.02
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension (2000) 3.01
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00
Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int (2006) 2.85
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med (1991) 2.74
Coeliac syndrome in dermatitis herpetiformis. Lancet (1968) 2.73
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. J Am Coll Cardiol (1993) 2.72
Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol (1996) 2.71
The courts and health policy: strengths and limitations. Health Aff (Millwood) (1992) 2.65
Detection of a novel human class II HLA antigen. Nature (1983) 2.61
Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med (1993) 2.55
Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc (1998) 2.54
Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol (2001) 2.53
Trends in Medicare reimbursement for end-stage renal disease: 1974-1979. Health Care Financ Rev (1984) 2.44
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr (1991) 2.39
Capitation pricing: adjusting for prior utilization and physician discretion. Health Care Financ Rev (1986) 2.39
The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financ Rev (1984) 2.35
Undetected eye disease in a primary care clinic population. Arch Intern Med (1994) 2.32
A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA (1993) 2.25
Predicting hospital readmissions in the Medicare population. Inquiry (1985) 2.20
Observation unit treatment of heart failure with nesiritide: results from the proaction trial. J Emerg Med (2005) 2.19
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
End-stage renal disease attributable to diabetes mellitus. Ann Intern Med (1994) 2.16
The first 3 years of Medicare prospective payment: an overview. Health Care Financ Rev (1988) 2.16
Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med (1995) 2.12
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med (2001) 2.08
Transition from maternal to embryonic control in early mammalian development: a comparison of several species. Mol Reprod Dev (1990) 2.07
Effects of lecture information density on medical student achievement. J Med Educ (1984) 2.06
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA (1997) 2.06
Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia (1993) 2.05
Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res (2000) 2.05
Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2001) 2.03
Selection of initial antihypertensive drug therapy. Lancet (2000) 2.02
Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci (1995) 2.01
New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med (2000) 2.00
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension (2000) 1.96
Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol (1991) 1.94
Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. Chest (1991) 1.91
Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension (1980) 1.86
Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J (1999) 1.83
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
End-stage renal disease in US minority groups. Am J Kidney Dis (1992) 1.74
The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. J Anat (1975) 1.73
Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc Natl Acad Sci U S A (1997) 1.73
Financing graduate medical education using multiple regression to set payment rates. Inquiry (1986) 1.68
Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension (2001) 1.68
Universal health care coverage in Korea. Health Aff (Millwood) (1989) 1.67
Small intestine in psoriasis. Br Med J (1967) 1.66
Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med (1993) 1.65
Variation in indications for cataract surgery in the United States, Denmark, Canada, and Spain: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol (1998) 1.64
Primary biliary cirrhosis--a revised clinical spectrum. Lancet (1981) 1.64
Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int (1996) 1.63
Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health (1988) 1.63
Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. Hypertension (1995) 1.62
Comparison of risk adjusters for medicaid-enrolled children with and without chronic health conditions. Ambul Pediatr (2002) 1.61
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Capitation adjustment for pediatric populations. Pediatrics (1996) 1.58
Prevalence of cardiovascular risk factors in South Korean adults: results from the Korea Medical Insurance Corporation (KMIC) Study. Ann Epidemiol (1998) 1.55
Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol (1998) 1.54
Decline in US stroke mortality. Demographic trends and antihypertensive treatment. Stroke (1989) 1.54
Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease. Med Decis Making (1995) 1.54
Results of colectomy in elderly patients with colon cancer, based on Medicare claims data. Am J Surg (1992) 1.53
Left ventricular hypertrophy and skin color among American blacks. Am J Epidemiol (1991) 1.52
International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology (1997) 1.51
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev (2006) 1.51
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension (1998) 1.51
Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. Am J Kidney Dis (1993) 1.48
Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke (2001) 1.48
Blood transfusion costs: a multicenter study. Transfusion (1991) 1.48
Liver damage after paracetamol overdose. Comparison of liver-function tests, fasting serum bile acids, and liver histology. Lancet (1975) 1.46
The content and cost of cataract surgery. Arch Ophthalmol (1993) 1.44